SS
RDHL

Steve Schonfeld’s Redhill Biopharma RDHL Stock Holding History

Steve Schonfeld’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23
Closed -$187K – 2069
2020
Q4 		$187K Sell
23
-132
-85% -$1.19M ﹤0.01% 1358
2020
Q3 		$1.59M Buy
155
+55
+55% +$451K 0.03% 575
2020
Q2 		$671K Sell
100
-25
-20% -$172K 0.02% 717
2020
Q1 		$566K Buy
125
+108
+635% +$540K 0.04% 541
2019
Q4 		$104K Buy
+17
New +$109K ﹤0.01% 1208

Other funds holding RDHL

II
Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Steve Schonfeld's RDHL Position: Q1 2021 in Review

Steve Schonfeld sold out of Redhill Biopharma (RDHL) in Q1 2021, closing a stake of 23 shares — an estimated $187K sold.

Steve Schonfeld first reported a position in RDHL in Q4 2019 and held it in 5 quarters. The position peaked at $1.59M in Q3 2020. 55 funds tracked by Wall St. Rank hold RDHL as of Q1 2021.

  • Steve Schonfeld reported no remaining Redhill Biopharma position as of Q1 2021 after selling out during the quarter.
  • Steve Schonfeld sold 23 Redhill Biopharma shares in Q1 2021, an estimated $187K.
  • Steve Schonfeld first reported a position in Redhill Biopharma in Q4 2019 and held it in 5 quarters.
  • Steve Schonfeld's Redhill Biopharma position peaked at $1.59M in Q3 2020.
  • 55 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2021, filed 17 May 2021.